Table of Contents 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Molecular Diagnostics in Cancer Testing Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis 2 Market Analysis by Types 2.1 Overall Market Performance(Volume) 2.1.1 Type I Market Performance (Volume) 2.1.2 Type II Market Performance (Volume) 2.2 Overall Market Performance(Value) 2.1.1 Type I Market Performance (Value) 2.1.2 Type II Market Performance (Value) 3 Product Application Market 3.1 Overall Market Performance (Volume) 3.1.1 Application 1 Market Performance (Volume) 3.1.2 Application 2 Market Performance (Volume) 4 Manufacturers Profiles/Analysis 4.1 Abbott Molecular Diagnostics 4.1.1 Abbott Molecular Diagnostics Profiles 4.1.2 Abbott Molecular Diagnostics Product Information 4.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Performance 4.1.4 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.2 Accugenomics 4.2.1 Accugenomics Profiles 4.2.2 Accugenomics Product Information 4.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Business Performance 4.2.4 Accugenomics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.3 Agendia 4.3.1 Agendia Profiles 4.3.2 Agendia Product Information 4.3.3 Agendia Molecular Diagnostics in Cancer Testing Business Performance 4.3.4 Agendia Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.4 Ambry Genetics 4.4.1 Ambry Genetics Profiles 4.4.2 Ambry Genetics Product Information 4.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.4.4 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.5 Biodesix 4.5.1 Biodesix Profiles 4.5.2 Biodesix Product Information 4.5.3 Biodesix Molecular Diagnostics in Cancer Testing Business Performance 4.5.4 Biodesix Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.6 bioMerieux 4.6.1 bioMerieux Profiles 4.6.2 bioMerieux Product Information 4.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Business Performance 4.6.4 bioMerieux Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.7 bioTheranostics (AviaraDx) 4.7.1 bioTheranostics (AviaraDx) Profiles 4.7.2 bioTheranostics (AviaraDx) Product Information 4.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Performance 4.7.4 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.8 Cancer Genetics 4.8.1 Cancer Genetics Profiles 4.8.2 Cancer Genetics Product Information 4.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.8.4 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.9 Clarient, Inc. (GE Healthcare) 4.9.1 Clarient, Inc. (GE Healthcare) Profiles 4.9.2 Clarient, Inc. (GE Healthcare) Product Information 4.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Performance 4.9.4 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.10 Counsyl 4.10.1 Counsyl Profiles 4.10.2 Counsyl Product Information 4.10.3 Counsyl Molecular Diagnostics in Cancer Testing Business Performance 4.10.4 Counsyl Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.11 Flatiron Health 4.12 Epigenomics 4.13 Agendia 4.14 Ambry Genetics 4.15 Biodesix 5 Market Performance for Manufacturers 5.1 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Market Share by Manufacturers 2013-2018 5.2 Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018 5.3 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 5.4 Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 5.5 Market Concentration 6 Regions Market Performance for Manufacturers 6.1 Germany Market Performance for Manufacturers 6.1.1 Germany Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.1.2 Germany Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.1.3 Germany Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.1.4 Germany Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.1.5 Market Concentration 6.2 UK Market Performance for Manufacturers 6.2.1 UK Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.2.2 UK Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.2.3 UK Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.2.4 UK Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.2.5 Market Concentration 6.3 France Market Performance for Manufacturers 6.3.1 France Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.3.2 France Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.3.3 France Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.3.4 France Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.3.5 Market Concentration 6.4 Russia Market Performance for Manufacturers 6.4.1 Russia Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.4.2 Russia Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.4.3 Russia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.4.4 Russia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.4.5 Market Concentration 6.5 Benelux Market Performance for Manufacturers 6.5.1 Benelux Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.5.2 Benelux Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.5.3 Benelux Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.5.4 Benelux Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.5.5 Market Concentration 6.6 Italy Market Performance for Manufacturers 6.6.1 Italy Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.6.2 Italy Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.6.3 Italy Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.6.4 Italy Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.6.5 Market Concentration 6.7 Spain Market Performance for Manufacturers 6.7.1 Spain Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.7.2 Spain Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.7.3 Spain Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.7.4 Spain Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.7.5 Market Concentration 6.8 Market Performance for Manufacturers 6.8.1 Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.8.2 Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.8.3 Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.8.4 Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.8.5 Market Concentration 7 Europe Molecular Diagnostics in Cancer Testing Market Performance (Sales Point) 7.1 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Market Share by Regions 2013-2018 7.2 Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Regions 2013-2018 7.3 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018 7.4 Europe Molecular Diagnostics in Cancer Testing Gross Margin by Regions 2013-2018 8 Development Trend for Regions (Sales Point) 8.1 Europe Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.2 Germany Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.3 UK Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.4 France Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.5 Russia Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.6 Benelux Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.7 Italy Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.8 Spain Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 8.8 Spain Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9 Upstream Source, Technology and Cost 9.1 Upstream Source 9.2 Technology 9.3 Cost 10 Channel Analysis 10.1 Market Channel 10.2 Distributors 11 Consumer Analysis 11.1 Application 1 Industry 11.2 Application 2 Industry 12 Market Forecast 2019-2024 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024 12.1.1 Europe Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024 12.1.2 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2019-2024 12.1.3 Germany Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.4 UK Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.5 France Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.6 Russia Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.7 Benelux Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.8 Italy Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.9 Spain Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024 12.3.1 Overall Market Performance 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.4 Sales by Application 2019-2024 12.4.1 Overall Market Performance 12.4.2 Application 1 Sales and and Growth Rate 2019-2024 12.4.3 Application 2 Sales and and Growth Rate 2019-2024 12.5 Price (USD/Unit) and Gross Profit 12.5.1 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) Trend 2019-2024 12.5.2 Europe Molecular Diagnostics in Cancer Testing Gross Profit Trend 2019-2024 13 Conclusion

List of Tables and Figures Figure Product Picture of Molecular Diagnostics in Cancer Testing Table Product Specifications of Molecular Diagnostics in Cancer Testing Table Manufacturers List in the Report Table Manufacturers Production Market Share (%) 2013-2018 Table Regions Overview in 2017 Table Product Type and Standard Table Type Overview in 2017 Table Product Application and Standard Table Application Overview in 2017 Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing Table Industry News List of Molecular Diagnostics in Cancer Testing Figure New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) by Types Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Types in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Types in 2018 Table Type I Sales (K Units) and Growth Rate Figure Type I Sales (K Units) and Growth Rate Table Type II Sales (K Units) and Growth Rate Figure Type II Sales (K Units) and Growth Rate Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) by Types Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Types in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Types in 2018 Table Type I Revenue (M USD) and Growth Rate Figure Type I Revenue (M USD) and Growth Rate Table Type II Revenue (M USD) and Growth Rate Figure Type II Revenue (M USD) and Growth Rate Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) by Application 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table Application 1 Sales (K Units) and Growth Rate 2013-2018 Figure Application 1 Sales (K Units) and Growth Rate 2013-2018 Table Application 2 Sales (K Units) and Growth Rate 2013-2018 Figure Application 2 Sales (K Units) and Growth Rate 2013-2018 Table Abbott Molecular Diagnostics Profiles Table Abbott Molecular Diagnostics Product Information Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Accugenomics Profiles Table Accugenomics Product Information Table Accugenomics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Agendia Profiles Table Agendia Product Information Table Agendia Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Ambry Genetics Profiles Table Ambry Genetics Product Information Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Biodesix Profiles Table Biodesix Product Information Table Biodesix Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioMerieux Profiles Table bioMerieux Product Information Table bioMerieux Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioTheranostics (AviaraDx) Profiles Table bioTheranostics (AviaraDx) Product Information Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Cancer Genetics Profiles Table Cancer Genetics Product Information Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Profiles Table Clarient, Inc. (GE Healthcare) Product Information Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Counsyl Profiles Table Counsyl Product Information Table Counsyl Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Europe Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table UK Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table UK Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure UK Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table UK Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table UK Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure UK Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table UK Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure UK Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table UK Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure UK Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure UK Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table France Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table France Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure France Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table France Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table France Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure France Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table France Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure France Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table France Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure France Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure France Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Russia Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Russia Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Russia Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Russia Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Russia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Russia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Russia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Russia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Russia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Russia Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Russia Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Benelux Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Benelux Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Benelux Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Benelux Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Benelux Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Benelux Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Benelux Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Benelux Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Benelux Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Benelux Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Benelux Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Italy Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Italy Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Italy Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Italy Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Italy Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Italy Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Italy Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Italy Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Italy Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Italy Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Italy Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Spain Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Spain Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Spain Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Spain Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Spain Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Spain Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Spain Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Spain Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Spain Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Spain Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Spain Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) by Regions 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions in 2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) by Regions 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2018 Table Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions in 2018 Table Europe Molecular Diagnostics in Cancer Testing Gross Margin by Regions 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin by Regions in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin by Regions in 2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Germany Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Germany Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure UK Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure France Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Russia Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Benelux Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Italy Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Spain Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Table Upstream Source for Manufacturers Table Manufacture Technology of Molecular Diagnostics in Cancer Testing Figure Cost Structure of Molecular Diagnostics in Cancer Testing in 2018 Table Europe Molecular Diagnostics in Cancer Testing Production (K Units) by Regions 2019-2024 Table Europe Molecular Diagnostics in Cancer Testing Production Market Share (%) by Regions 2019-2024 Figure Europe Molecular Diagnostics in Cancer Testing Production Market Share (%) by Regions in 2019 Figure Europe Molecular Diagnostics in Cancer Testing Production Market Share (%) by Regions in 2024 Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) by Regions 2019-2024 Table Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions 2019-2024 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2019 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2024 Figure Europe Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Germany Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Germany Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure UK Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure UK Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure France Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure France Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Russia Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Russia Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Benelux Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Benelux Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Italy Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Italy Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Spain Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Spain Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Figure Molecular Diagnostics in Cancer Testing Production (K Units) and Growth Rate 2019-2024 Figure Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2019-2024 Table Europe Molecular Diagnostics in Cancer Testing Production (K Units) by Types 2019-2024 Figure Europe Molecular Diagnostics in Cancer Testing Production Market Share (%) by Types in 2019 Figure Europe Molecular Diagnostics in Cancer Testing Production Market Share (%) by Types in 2024 Table Type I Production (K Units) and Growth Rate Table Type I Revenue (M USD) and Growth Rate Table Type II Production (K Units) and Growth Rate Table Type II Revenue (M USD) and Growth Rate Table Europe 2019-2024 Molecular Diagnostics in Cancer Testing Sales by Application Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2019 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2024 Figure Application 1 Sales and Growth Rate 2019-2024

Abbott Molecular Diagnostics Accugenomics Agendia Ambry Genetics Biodesix bioMerieux bioTheranostics (AviaraDx) Cancer Genetics Clarient, Inc. (GE Healthcare) Counsyl Flatiron Health Epigenomics Exact Sciences Corporation Exiqon Genomic Health